Comparison of histologic lesions of endophthalmitis induced by Blastomyces dermatitidis in untreated and treated dogs: 36 Cases (1986-2001)

Journal of the American Veterinary Medical Association

Volumn 224, Issue 8, 2004, Pages 1317-1322

  Hendrix, Diane V H ^a   Rohrbach, Barton W ^a   Bochsler, Philip N ^a,d   English, Robert V ^b,c  

^a UNIVERSITY OF TENNESSEE   (United States)

^b Animal Eye Care Associates   (United States)

^c NORTH CAROLINA STATE UNIVERSITY   (United States)

^d UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ITRACONAZOLE;

ANIMAL TISSUE; ARTICLE; BLASTOMYCES DERMATITIDIS; CATARACT; CLINICAL FEATURE; CONTROLLED STUDY; DOG; ENDOPHTHALMITIS; FEMALE; FUNGAL REPRODUCTION; FUNGUS CULTURE; HISTOPATHOLOGY; INFLAMMATION; MALE; NONHUMAN; PREVALENCE; RETROSPECTIVE STUDY; SCORING SYSTEM;

ANIMALS; ANTIFUNGAL AGENTS; BLASTOMYCES; BLASTOMYCOSIS; DOG DISEASES; DOGS; ENDOPHTHALMITIS; FEMALE; ITRACONAZOLE; LENS, CRYSTALLINE; MALE; RETROSPECTIVE STUDIES;

AJELLOMYCES DERMATITIDIS; ANIMALIA; BLASTOMYCES; CANIS FAMILIARIS; FUNGI;

EID: 1942536000     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: 10.2460/javma.2004.224.1317     Document Type: Article

References (34)

1. Legendre AM. Blastomycosis. In: Green CE, ed. Infectious diseases of the dog and cat. 2nd ed. Philadelphia: WB Saunders Co, 1998;371-377.
2. Brooks DE, Legendre AM, Gum GG, et al. The treatment of canine ocular blastomycosis with systemically administered itraconazole. Prog Vet Comp Ophthalmol 1991;1:263-268.
3. Arceneaux KA, Taboada J, Hosgood G. Blastomycosis in dogs: 115 cases (1980-1995). J Am Vet Med Assoc 1998;213:658-664.
4. Legendre AM, Walker MA, Buyukmihci N, et al. Canine blastomycosis: a review of 47 clinical cases. J Am Vet Med Assoc 1981;178:1163-1168.
5. Buyukmihci N. Ocular lesions of blastomycosis in the dog. J Am Vet Med Assoc 1982;180:426-431.
6. Bloom JD, Hamor RE, Gerding PA. Ocular blastomycosis in dogs: 73 cases, 108 eyes (1985-1993). J Am Vet Med Assoc 1996;209:1271-1274.
7. Buyukmihci NC, Moore PF. Microscopic lesions of spontaneous ocular blastomycosis in dogs. J Comp Pathol 1987;97:321-328.
8. Legendre AM, Rohrbach BW, Toal RL, et al. Treatment of blastomycosis with itraconazole in 112 dogs. J Vet Intern Med 1996;10:365-371.
9. Luna LG, ed. Methods for bacteria, fungi, and inclusion bodies. In: Manual of histologic staining methods of the American Institute of Pathology. 3rd ed. New York: McGraw-Hill Book Co, 1968;217-241.
10. Savani DV, Perfect JR, Cobo LM, et al. Penetration of new azole compounds into the eye and efficacy in experimental Candida endophthalmitis. Antimicrob Agents Chemother 1987;31:6-10.
11. Chapman SW, Rogers PD, Rinaldi MG, et al. Susceptibilities of clinical and laboratory isolates of Blastomyces dermatitidis to ketoconazole, itraconazole, and fluconazole. Antimicrob Agents Chemother 1998;42:978-980.
12. Streilein JW, Niederkorn JY. Induction of anterior chamber-associated immune deviation requires an intact, functional spleen. J Exp Med 1981;153:1058-1067.
13. Whittum JA, Niederkorn JY, McCulley JP, et al. Intracameral inoculation of herpes simplex virus type I induces anterior chamber associated immune deviation. Curr Eye Res 1982;2:691-697.
14. Streilein JW, Ma N, Wenkel H, et al. Immunobiology and privilege of neuronal retina and pigment epithelium transplants. Vision Res 2002;42:487-495.
15. Wenkel H, Streilein JW. Analysis of immune deviation elicited by antigens injected into the subretinal space. Invest Ophthalmol Vis Sci 1998;39:1823-1834.
16. Streilein JW. Immunological non-responsiveness and acquisition of tolerance in relation to immune privilege in the eye. Eye 1995;9:236-240.
17. Drutz DJ, Frey CL. Intracellular and extracellular defenses of human phagocytes against Blastomyces dermatitidis conidia and yeasts. J Lab Clin Med 1985;105:737-750.
18. Kozel TR. Activation of the complement system by pathogenic fungi. Clin Microbiol Rev 1996;9:34-46.
19. Zhang MX, Klein BS. Activation, binding, and processing of complement component 3 (C3) by Blastomyces dermatitidis. Infect Immun 1997;65:1849-1855.
20. Klein BS. Molecular basis of pathogenicity in Blastomyces dermatitidis: the importance of adhesion. Curr Opin Microbiol 2000;3:339-343.
21. Klein BS, Squires RA, Lloyd JK, et al. Canine antibody response to Blastomyces dermatitidis WI-1 antigen. Am J Vet Res 2000;61:554-558.
22. Wüthrich M, Chang WL, Klein BS. Immunogenicity and protective efficacy of the WI-1 adhesin of Blastomyces dermatitidis. Infect Immun 1998;66:5443-5449.
23. Abuodeh RO, Winston V, Scalarone GM. Induction and detection of cell-mediated reactions with different Blastomyces dermatitidis antigenic preparations. Mycoses 1996;39:85-93.
24. Finkel-Jimenez B, Wüthrich M, Brandhorst T, et al. The WI-1 adhesin blocks phagocyte TNF-alpha production, imparting pathogenicity on Blastomyces dermatitidis. J Immunol 2001;166:2665-2673.
25. Wüthrich M, Klein BS. Investigation of anti-WI-1 adhesin antibody-mediated protection in experimental pulmonary blastomycosis. J Infect Dis 2000;181:1720-1728.
26. Wüthrich M, Finkel-Jiminez BE, Klein BS. Interleukin 12 as an adjuvant to WI-1 adhesin immunization augments delayed-type hypersensitivity, shifts the subclass distribution of immunoglobulin G antibodies, and enhances protective immunity to Blastomyces dermatitidis infection. Infect Immun 2000;68:7172-7174.
27. Hara Y, Caspi RR, Wiggert B, et al. Suppression of experimental autoimmune uveitis in mice by induction of anterior chamber-associated immune deviation with interphotoreceptor retinoid-binding protein. J Immunol 1992;148:1685-1692.
28. Griffith TS, Brunner T, Fletcher SM, et al. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 1995;270:1189-1192.
29. Griffith TS, Yu X, Herndon JM, et al. CD95-induced apoptosis of lymphocytes in an immune privileged site induces immunological tolerance. Immunity 1996;5:7-16.
30. Kezuka T, Streilein JW. Evidence for multiple CD95-CD95 ligand interactions in anterior chamber-associated immune deviation induced by soluble protein antigen. Immunology 2000;99:451-457.
31. Safneck J, Hogg G, Napier L. Endopthalmitis due to Blastomyces dermatitidis. Ophthalmol 1990;97:212-216.
32. Yanoff M, Fine BS. Lens. In: Ocular pathology: a text and atlas. 3rd ed. Philadelphia: JB Lippincott Co, 1989:347-376.
33. Wilcock BP, Peiffer RL. The pathology of lens-induced uveitis in dogs. Vet Pathol 1987;24:549-553.
34. Eagle RC, Spencer WH. Lens. In: Spencer WH, ed. Ophthalmic pathology. Vol 1. 4th ed. Philadelphia: WB Saunders Co, 1996;372-437.